Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Transpek Industry
Join Channel
Consolidated Standalone

Transpek Industry

₹1691.5 9.3 | 0.6%

Market Cap ₹945 Cr.

Stock P/E 17.1

P/B 1.5

Current Price ₹1691.5

Book Value ₹ 1127.4

Face Value 10

52W High ₹2287

Dividend Yield 1.63%

52W Low ₹ 1615

Edit Ratio

Transpek Industry Research see more...

Overview Inc. Year: 1965Industry: Pesticides & Agrochemicals

Transpek Industry Ltd is a holding business enterprise. The Company is engaged inside the production and export of a number of chemical substances servicing customers from numerous industries. The Company manufactures various other chemical merchandise, such as anti-knock preparations, anti-freeze preparations, drinks for hydraulic transmission, composite diagnostic or laboratory reagents, writing or drawing ink, chemical substance utilized in manufacturing of pesticides and other chemical product. The Company also manufactures natural and inorganic chemical substances. Its natural products encompass Tri Ethylene Glycol Dichloride, Cetyl Chloride, Pivaloyl Chloride and Terephthaloyl Chloride. Its inorganic products includeSulphur Trioxide, Chloro Sulphonic Acid, Thionyl Chloride, and Sulphur Monochloride, . The Company's products are utilized in various programs, such as polymers, plastics, overall performance substances, agrochemicals, coatings, pharmaceuticals, personal care, flavours and perfume.

Read More..

Transpek Industry Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Transpek Industry Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 155 180 143 211 216 196 203 162 121 148
Other Income 4 11 4 4 4 4 5 12 4 5
Total Income 158 191 147 216 221 200 208 174 125 153
Total Expenditure 124 149 126 182 181 154 163 140 108 121
Operating Profit 34 42 20 34 40 46 45 34 17 32
Interest 3 3 3 4 5 5 6 4 3 4
Depreciation 7 8 8 8 8 8 8 9 9 9
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 24 31 10 22 27 33 31 21 6 20
Provision for Tax 7 9 -2 6 7 8 9 5 3 6
Profit After Tax 18 23 11 16 20 25 22 16 3 14
Adjustments -0 0 0 0 0 0 -0 0 0 0
Profit After Adjustments 18 23 11 16 20 25 22 16 3 14
Adjusted Earnings Per Share 31.5 41.1 20.2 29.4 35.8 44.3 40.1 28.4 5.4 25.2

Transpek Industry Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 242 269 290 284 317 361 595 566 339 599 827 634
Other Income 4 8 6 4 7 10 18 17 17 29 18 26
Total Income 246 277 295 288 324 371 612 583 357 628 845 660
Total Expenditure 216 242 251 237 264 314 478 448 292 503 680 532
Operating Profit 30 35 44 51 60 57 134 135 64 125 165 128
Interest 14 14 13 11 9 12 19 16 10 11 19 17
Depreciation 8 9 9 8 9 10 14 26 29 30 33 35
Exceptional Income / Expenses 0 0 5 0 0 0 0 0 0 0 0 0
Profit Before Tax 8 12 27 32 42 35 101 94 26 84 113 78
Provision for Tax 1 5 5 10 12 9 36 21 2 19 29 23
Profit After Tax 7 8 22 21 30 26 66 73 23 65 83 55
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 7 8 22 21 30 26 66 73 23 65 83 55
Adjusted Earnings Per Share 12.5 12.8 37.4 36.2 53.7 47.3 117.7 130.6 41.7 117.1 149.5 99.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 38% 13% 18% 13%
Operating Profit CAGR 32% 7% 24% 19%
PAT CAGR 28% 4% 26% 28%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -8% 8% 4% 25%
ROE Average 16% 12% 17% 19%
ROCE Average 21% 15% 19% 20%

Transpek Industry Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 51 56 75 91 206 247 311 338 380 484 587
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 33 16 30 26 25 85 69 45 44 35 28
Other Non-Current Liabilities 11 16 18 18 46 51 64 70 69 79 137
Total Current Liabilities 124 156 106 74 109 183 154 136 106 166 136
Total Liabilities 219 244 229 209 386 566 599 589 599 764 887
Fixed Assets 113 106 92 94 117 179 236 287 287 295 365
Other Non-Current Assets 14 20 19 20 150 211 189 143 158 225 287
Total Current Assets 93 118 118 95 119 177 173 159 154 244 234
Total Assets 219 244 229 209 386 566 599 589 599 764 887

Transpek Industry Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 1 2 2 1 2 0 1 0 0 15 2
Cash Flow from Operating Activities 20 26 19 44 47 7 128 111 35 47 111
Cash Flow from Investing Activities -5 -9 14 -16 -31 -103 -45 -33 -17 -70 -13
Cash Flow from Financing Activities -14 -17 -33 -27 -17 96 -83 -77 -3 9 -94
Net Cash Inflow / Outflow 1 -0 -0 1 -1 0 -0 0 15 -14 4
Closing Cash & Cash Equivalent 2 2 1 2 0 1 0 0 15 2 5

Transpek Industry Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 12.52 12.83 37.41 36.24 53.67 47.27 117.69 130.59 41.74 117.09 149.45
CEPS(Rs) 26.79 28.14 53.42 50.38 69.12 65.04 143.01 176.96 92.77 170.31 208.57
DPS(Rs) 3 2.5 5 7.5 9 9 20 12.5 7.5 22.5 27.5
Book NAV/Share(Rs) 86.01 95.92 127.33 154.54 368.13 442.09 557.51 605.92 679.98 867.04 1050.26
Core EBITDA Margin(%) 10.45 9.71 12.55 15.87 16.08 12.95 19.61 20.83 13.9 15.99 17.77
EBIT Margin(%) 8.67 9.28 13.07 14.36 15.72 12.9 20.23 19.32 10.59 15.81 15.94
Pre Tax Margin(%) 3.21 4.36 8.78 10.75 12.94 9.63 17.04 16.52 7.52 14.05 13.62
PAT Margin (%) 2.91 2.69 7.23 7.22 9.15 7.26 11.06 12.89 6.87 10.91 10.08
Cash Profit Margin (%) 6.23 5.9 10.33 10.04 11.78 9.99 13.43 17.46 15.26 15.87 14.06
ROA(%) 3.4 3.25 9.29 9.72 10.06 5.54 11.28 12.29 3.92 9.59 10.11
ROE(%) 15.36 14.1 33.52 25.71 20.23 11.67 23.55 22.45 6.49 15.14 15.59
ROCE(%) 14.32 16.63 25.63 27.58 22.98 12.62 26.57 24.27 7.81 17.43 20.66
Receivable days 72.96 84.04 93.49 79.21 63.12 80.65 57.37 59.07 89.16 53.36 47.88
Inventory Days 45.32 41.11 36.89 40.35 41.68 41.69 31.33 34.1 46.44 31.31 28.94
Payable days 123.98 124.42 126.2 97.06 66.62 83.88 68.95 78.11 99.15 53.67 46.13
PER(x) 5.3 9.31 6.45 10.93 11 26.09 12.77 9.41 32.67 16.66 9.84
Price/Book(x) 0.77 1.25 1.89 2.56 1.6 2.79 2.7 2.03 2.01 2.25 1.4
Dividend Yield(%) 4.52 2.09 2.07 1.89 1.52 0.73 1.33 1.02 0.55 1.15 1.87
EV/Net Sales(x) 0.58 0.62 0.75 1.03 1.32 2.46 1.65 1.4 2.46 1.95 1.06
EV/Core EBITDA(x) 4.63 4.79 4.94 5.79 6.92 15.66 7.31 5.86 12.94 9.38 5.3
Net Sales Growth(%) 31.69 11.2 7.57 -2.04 11.59 14.08 64.64 -4.87 -40 76.52 38.02
EBIT Growth(%) 557.52 18.75 52.76 6.61 21.73 -8.91 156.33 -9.06 -67.13 163.67 39.3
PAT Growth(%) 146.38 2.5 191.6 -3.14 40.88 -11.92 148.98 10.96 -68.04 180.55 27.64
EPS Growth(%) 146.38 2.5 191.6 -3.14 48.1 -11.92 148.98 10.96 -68.04 180.55 27.64
Debt/Equity(x) 2.07 1.8 1.04 0.7 0.43 0.82 0.46 0.32 0.25 0.27 0.13
Current Ratio(x) 0.74 0.75 1.11 1.28 1.09 0.97 1.12 1.17 1.44 1.47 1.73
Quick Ratio(x) 0.51 0.54 0.85 0.77 0.75 0.72 0.76 0.8 1.1 1.07 1.25
Interest Cover(x) 1.59 1.89 3.05 3.98 5.66 3.94 6.34 6.9 3.45 8.99 6.87
Total Debt/Mcap(x) 2.68 1.44 0.55 0.27 0.27 0.29 0.17 0.16 0.12 0.12 0.1

Transpek Industry Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 57.48 57.48 57.48 57.48 57.48 57.47 57.47 57.47 57.47 57.47
FII 1.83 1.83 1.85 1.85 1.85 1.8 1.85 1.87 0.96 0.05
DII 3 2.85 2.83 2 1.99 1.79 1.79 1.79 1.79 1.79
Public 37.69 37.84 37.84 38.67 38.68 38.94 38.89 38.88 39.79 40.69
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 26% CAGR over last 5 years
  • Debtor days have improved from 53.67 to 46.13days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 12% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Transpek Industry News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!